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Objective: Currently, the best approach to the aortic arch remains unsupported by robust evidence. Most of the available
data rely on small sample numbers, heterogeneous settings, and limited follow-up. The objective of this study was to
evaluate early and midterm results of arch debranching and endovascular procedures.
Methods: From 2005 through 2013, 104 consecutive patients underwent elective arch treatment with debranching and
thoracic endovascular aortic repair. Rates of perioperative (30-day) mortality and neurological complications, and
mortality, endoleak, supra-aortic vessel patency, and arch diameter changes at 5 years were analyzed.
Results: Patients’ mean age was 69.8 years, and 90 were males. Twenty arches were repaired for dissection. Nineteen
patients required total debranching for diseases extended to zone 0. In 59, debranching and thoracic endovascular aortic
repair procedures were staged. At 30 days, death, stroke, and spinal cord ischemia occurred in six, four, and three patients,
respectively. Extension to ascending aorta (zone 0 landing) was the only multivariate independent predictor for peri-
operative mortality (odds ratio, 9.6; 95% conﬁdence interval, 1.54-59.90; P[ .015), but not for stroke. Four retrograde
dissections, two fatal, occurred during the perioperative period. At 1, 3, and 5 years, Kaplan-Meier survival rates were
89.0%, 82.8%, and 70.9%, and freedom from persistent endoleak rates were 96.1%, 92.5%, and 88.3%, respectively. Over
5-year follow-up, 34 aneurysms shrank $5 mm, and four grew. Five reinterventions were required. Two supra-aortic
vessel occlusions and no late aorta-related mortalities were recorded.
Conclusions: Despite the perioperative mortality risk, the late outcome of endovascular arch repair presents a low rate of
aorta-related deaths and reinterventions and acceptable midterm survival. Furthermore, more than one-third of the
aneurysms’ diameters decrease over 5 years as ameasure of the long-term efﬁcacy of treatment. Retrograde type A dissection
remains a major concern in the perioperative period and careful arch approach is required. (J Vasc Surg 2014;59:107-14.)The feasibility of arch vessel debranching followed by
thoracic endovascular aortic repair (TEVAR) as a less inva-
sive alternative approach for treatment of arch diseases in
high-risk patients has been supported by several reports
and recent systematic reviews.1-4
Despite the increasing application of endovascular
treatment in aortic arch diseases over the last decade, there
is conﬂicting information as to the early safety with respect
to patients’ selection and disease extension, while the long-
term durability remains largely unsettled.4-13
Currently, the best approach to the aortic arch remains
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The aim of this study was to analyze early and midterm
outcomes in a consecutive series of patients undergoing
aortic arch debranching and endovascular procedures.
METHODS
All patients who underwent aortic arch endovascular
repair entered in a prospective database were reviewed
and included in the study. Patients were referred for treat-
ment at two tertiary vascular centers, the Unit of Vascular
and Endovascular Surgery, Hospital S. Camillo-Forlanini,
Rome, and the Unit of Vascular and Endovascular Surgery,
Hospital S. Maria della Misericordia, Perugia, Italy.
Reasons for referral included atherosclerotic or postdissec-
tion aortic arch aneurysms, posttraumatic aneurysm of the
aortic arch or isthmus, acute aortic dissections, penetrating
ulcers of the aortic arch, and aneurysms of aberrant subcla-
vian artery involving the aortic arch.
Patients undergoing TEVAR not requiring supra-aortic
vessels revascularization were excluded from this study.
Patient demographics and preoperative clinical data
were collected, including comorbidities, symptoms, disease,
and indication for operation (Table I). Aneurysm size and
extent of disease were determined based on three-
dimensional reconstructions of preoperative computed
tomography angiography (CTA) scans, using the cross-
sectional diameter of the aortic centerline. Operative details107
Table I. Baseline characteristics in 104 patients with arch
debranching procedures
Characteristics No. %
Mean age 6 SD, years 69.8 6 9.41 Range, 36-88
Males 90 86.5
Arch atherosclerotic aneurysm 69 66.3
Dissection 20 19.2
Chronic 18
Type A 9
Type B 9
Acute
Type B 2
PAU 3 2.8
Aberrant subclavian aneurysm 8 7.7
Posttraumatic aneurysm 4 3.9
Rupture 6 5.7
Urgent repair 7 6.7
Anatomical variants 19 18.3
Bovine 9
Right-sided 2
Aberrant subclavian 8
Prior aortic surgery
Ascending arch replacement 9 8.6
Abdominal aorta repair 14 13.4
Hypertension 90 86.5
Diabetes 15 14.4
COPD 32 30.8
Renal insufﬁciency 9 8.7
CAD 41 39.4
Hyperlipidemia 49 47
Marfan 1 0.9
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease; PAU, penetrating aortic ulcer; SD, standard deviation.
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used, and intraoperative complications.
Primary outcomes measured were 30-day mortality,
30-day neurologic morbidity (stroke, spinal cord ischemia),
and survival at 5 years. Secondary outcomes included rates
of endoleak, late aorta-related death, progression of disease
(aneurysm expansion $5 mm and retrograde dissection
extent), and patency of supra-aortic vessels at 5 years.
Technical success was deﬁned by complete exclusion of
the diseased aorta without type I or III endoleak on
completion angiography and without need for conversion
to an open procedure.7 Retrograde ﬂow in uncovered
segments of aorta from distal entry tears were not consid-
ered as endoleaks after procedures for aortic dissections.16
Follow-up evaluations were conducted at 1, 6, and
12 months, and yearly thereafter using CTA scans to
monitor endoleaks and aneurysm sac geometry.
Operative techniques. Techniques performed were
either hybrid or endovascular procedures (chimney tech-
nique or single branched stent graft) or a combination of
both to ensure proximal landing zone of at least 2.0 cm
for TEVAR.
According to the anatomical arch disease extension,
proximal landing zones were stratiﬁed using the classiﬁca-
tion proposed by Ishimaru and Mitchell.17
In zone 0, all four supra-aortic vessels were revascular-
ized either using total debranching through mediansternotomy or using partial debranching associated with
branched stent graft or chimney techniques.
In zone 1, a carotid-carotid bypass using retropharyng-
eal or ante-trachea tunnel was performed in association
with left subclavian artery (LSA) revascularization by trans-
position or bypass.
In zone 2, carotid subclavian bypass or transposition
was performed. Details of repair are located in Table II
and Figs 1-3.
Subclavian (or vertebral) arteries were always revascu-
larized except in emergent cases. The subclavian artery
stump was occluded through oversewing, clipping, or
endovascular plug or coils.
Debranching was performed simultaneously or staged.
Since 2009, a single stage procedure has been the preferred
approach.
Preoperative cerebrospinal ﬂuid (CSF) drainage to
prevent cord ischemia was selectively used, based on length
of aortic coverage.
Rapid pacing was routinely used in zone 0. Alterna-
tively, in landing zones 1 and 2, controlled hypotension
was used for precise deployment. Transesophageal echocar-
diography was implemented in complicated dissections or
selectively in complex cases.
Stent grafts were deployed retrograde through femoral
access or by conduit for small diameter iliac arteries.
Various different commercially available stent graft
systems were used: the Cook-Zenith (Cook, Bloomington,
Ind), the Gore TAG and c-TAG (W. L. Gore & Assoc,
Flagstaff, Ariz), the Bolton Relay (Bolton Medical, Sunrise,
Fla), and the Talent and the Valiant (Medtronic Inc, Santa
Rosa, Calif). In addition, custom-made devices (one Bol-
ton Relay and three Cook Zenith) were used in four
patients with complex arch disease unmanageable with
commercially available devices (Table II).
The diameter of the stent graft was usually 10% to 20%
oversized, related to the outer diameter of the proximal
landing zone.
Statistical analysis. Statistical analysis was performed
using SPSS 17.0 software (SPS Inc. Chicago, Ill). Contin-
uous variables were summarized as mean 6 standard devi-
ation. Categoric variables were expressed as frequency and
percentages. The risk of 30-day death and the combined
risk of 30-day death and stroke were tested with adjusted
analyses using binary logistic regression with backward
stepwise model. The following most relevant factors for
mortality and stroke were entered in the model to test
their independent association with outcome: age, gender,
one-stage procedure, total debranching, and dissection.
Results were expressed as odds ratio (OR) and corre-
sponding conﬁdence intervals (CIs). Long-term results
were assessed using Kaplan-Meier analyses and displayed
until standard error of 10%. P values < .05 were regarded
as statistically signiﬁcant.
RESULTS
Between February 2005 and February 2013, endovas-
cular arch repair was performed in 104 consecutive
Table II. Technical details in 104 arch debranching procedures
Technical details No. (%) Procedure description
Staged procedure 59 (56.7)
Zone 0 19 (18.3) 16 total surgical debranching
1 single (innominate) chimney stent graft þ Car-Car-Subcl
1 single (innominate) branched stent graft þ Car-Car-Subcl
1 triple chimney stent graft
Zone 1 51 (49.0) Surgical bypass/transposition:
37 Car-Car-Subcl (20 retropharyngeal; 17 ante-trachea)
2 Car-Car (ante-trachea)
6 Car-Subcl (bovine arch)
6 bilateral Car-Subcl: 4 aberrant Subcl
2 aberrant Subcl þ bovine arch
Zone 2 34 (32.7) 31 Car-Subcl
3 single (left Subcl) chimney stent graft
Number of aortic stent grafts/repairsa 150/103 (1 patient died after 1 stage)
59 Single stent graft
39: Two aortic stent grafts
4: Three aortic stent grafts
1: Four aortic stent grafts
Car, Carotid; Car-Car, right common carotid-left common carotid surgical bypass; Car-Car-Subcl, right common carotid-left common carotid-left subclavian
surgical bypass/transposition; Car-Subcl, common carotid-subclavian surgical bypass/transposition; Subcl, subclavian; TEVAR, thoracic endovascular aortic
repair.
In two patients, left subclavian arteries not revascularized because of urgency or direct vertebral revascularization.
aDevice models employed in the 103 TEVARs included: 46 Cook Zenith, 22 Gore TAG-C-TAG, 26 Medtronic Talent/Valiant, 9 Bolton Relay.
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ings, and indication for treatment are described in Table I.
In detail, all of the nine patients with chronic type A
dissection have had previous ascending aorta replacement
and showed residual or recurrent dissection with arch aneu-
rysm at the time of current presentation.
Six patients were urgently treated for aortic rupture and
one for acute complicated type B dissection. Six more
patients presented symptoms of chest or back pain, hoarse-
ness, dysphagia, or dysphonia without signs of rupture on
preoperative CTA scan.
The only patient with Marfan disease treated in this
consecutive series had several previous operations with
bilateral pleurectomy.
Techniques used for supra-aortic vessels revascularization
are detailed in Table II. In summary, 19 patients (18.3%)
underwent total arch vessels debranching. In the remaining
85, single or multiple supra-aortic vessels debranching was
achieved with extra-thoracic bypass or transpositions, or
chimney stent graft (Table II; Figs 1-3). Six cases were
managed by chimney techniques or branched stent grafts:
four were total endovascular procedures (one three-vessel
arch chimney for zone 0 and three single LSA chimneys for
zone 2 repairs), and two were partially hybrid procedures
for zone 0 repairs (one innominate chimney and one innom-
inate branched thoracic stent graft, both associated with
carotid-carotid subclavian bypass).
LSA was not revascularized in two cases. For three
vertebral arteries, direct revascularization was performed.
In 52 procedures, the subclavian stump was occluded by
plug and/or coils without using surgical suture. Fifty-
nine (56.7%) of the hybrid procedures were staged. In
13, the endovascular second stage was performed under
local anesthetics.Rapid pacing was used in 45% of the procedures (n ¼
19, zone 0; n ¼ 21, zone 1; n ¼ 7, zone 2) and CSF
drainage in 2.9%, based on stent graft coverage extension
of the aorta. A conduit to allow stent graft placement
was required in two patients with small iliac arteries.
Perioperative outcome. At 30 days, six (5.8%) deaths,
four (3.8%) strokes, and three (2.9%) persistent deﬁcits of
spinal cord ischemia of any severity occurred (Table III).
In addition, two patients with transient symptoms of spinal
cord ischemia lasting <24 hours were successfully treated
with aggressive CSF drainage and blood pressure control.
Four 30-day deaths and one stroke occurred in patients
undergoing total arch debranching (landing zone 0); the
remaining two deaths and two strokes occurred in patients
with landing zone 1. No 30-day stroke or death developed
in patients undergoing procedures with landing zone 2.
Deaths were due to respiratory failure (n ¼ 2), aortic
rupture for retrograde de novo type A dissection (n ¼ 2),
stroke associated with spinal cord ischemia (n ¼ 1), and
myocardial infarction (n ¼ 1).
Two strokes were related to anterior cerebral ischemia
(one bilateral) and one to posterior cerebral ischemia after
partial debranching. In two of these patients, LSA revascular-
ization was not performed: one because of urgency and the
other because direct vertebral revascularization was used.
Total debranching (zone 0 landing) accounted for
a 30-day mortality risk signiﬁcantly higher than for the
partial debranching group (OR, 11.1; 95% CI, 1.86-
65.90; P ¼ .010). Thirty-day risk of stroke (OR, 1.5;
95% CI, 0.15-15.45; P ¼ .56) and spinal cord ischemia
(OR, 2.3; 95% CI, 0.19-26.82; P ¼ .46) were not signiﬁ-
cantly different in the total debranching group.
When the 30-day outcome was analyzed with multivar-
iate analysis adjusting for age, gender, type of disease
Fig 1. Total debranching (computed tomography angiography
[CTA] reconstructions). Bifurcated Dacron bypass from ascending
aorta to innominate and left subclavian (LSA) arteries; left
common carotid artery attached on the LSA branch associated
with thoracic endovascular aortic stent graft.
Fig 2. Total debranching (computed tomography angiography
[CTA] reconstructions). Innominate chimney and aortic stent
graft associated with carotid-carotid-subclavian bypass (in green
and red, respectively) with retropharyngeal tunnel.
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debranching extent, zone 0 landing was conﬁrmed as the
single independent predictor of death (OR, 9.6; 95% CI,
1.54-59.90; P ¼ .015). Zone 0 repair was not an indepen-
dent predictor of the combined risk of stroke/death (OR,
3.7; 95% CI, 0.82-16.7; P ¼ .09) as old age (OR, 1.18;
95% CI, 1.03-1.34; P ¼ .015) was.
Overall, four de novo type A retrograde dissections
were recorded at 30 days: three occurred in patients with
zone 0 repair (two were lethal) and one after 10 days in
a patient with zone 1 partial debranching who was success-
fully treated with ascending aorta replacement.
Technical success was achieved in 97.1% (100/103;
one patient died after the ﬁrst stage and did not undergo
aortic stent graft). Failures were due to three intraoperative
low-ﬂow type I endoleaks, all treated with a conservative
approach. Two spontaneously disappeared on follow-up
CTA scan (one was a reperfusion through the gutter of
a chimney graft and the other was a type Ia that required
repeated ballooning during the procedure). Only one
type I endoleak persisted with low ﬂow over follow-up
and was not associated with other complications or aneu-
rysm enlargement. Five type II intraoperative endoleaks
were recorded.Because of technical changes and increased experience
over the study period, major 30-day outcomes were
analyzed by procedural time. There was a trend for
decreased stroke rates, with only one event in the 75 proce-
dures performed after 2009, but without statistical rele-
vance (P ¼ .065). No relevant changes were noted in
mortality and spinal cord ischemia rates between the ﬁrst
and last 5 years of experience.
Late results. Mean follow-up was 29.26 19.9 months
(range, 1-79.5 months). No patient was lost. Twelve
patients died in follow-up. Causes of late deaths included
cardiac disease (n ¼ 3), stroke (n ¼ 2), cancer (n ¼ 2),
respiratory failure (n ¼ 1), infective disease (n ¼ 2), and
unknown cause (n ¼ 2). Kaplan-Meier survival rates were
89.0% at 1 year, 82.8% at 3 years, and 70.9% at 5 years
(Fig 4).
No aortic ruptures or aorta-related deaths were
recorded during follow-up.
Rates of freedom from persistent endoleak of any type
were 96.1% at 1 year, 92.5% at 3 years, and 88.3% at 5 years.
No persisting endoleaks occurred in the total debranching
group (Fig 5).
Overall, ﬁve reinterventions were performed up to
5 years, four of which were endovascular procedures
Fig 3. Zone 2 total endovascular repair on computed tomography
angiography (CTA) reconstructions: chimney for left subclavian
artery (LSA) and thoracic endovascular aortic stent graft.
Table III. Perioperative (30-day) major outcomes in
104 arch debranching procedures
Outcome measure No. %
Mortality 6 5.8
Stroke 4 3.8
Spinal cord ischemia 3 2.9
Technical success 100 97.1
Retrograde de novo type A dissection
d 1 intraoperative for zone 0 repaira
d 3 perioperative
B 2 lethal for zone 0 repairsb
B 1 for zone 1 repair @10 days
(successfully treated)
4 3.8
aOne intraoperative dissection occurred at the time of debranching and was
successfully treated with ascending aorta replacement followed by thoracic
endovascular repair (TEVAR).
bOne lethal dissection occurred in a staged procedure after the ﬁrst and
TEVAR stage was not performed; the second lethal dissection occurred after
a single stage procedure.
Fig 4. Survival in 104 patients with aortic arch debranching.
Fig 5. Freedom from persisting endoleak after aortic arch
debranching.
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endoleak (one was a type Ib endoleak associated with prox-
imal migration at 24 months), and one was subclavian
stump embolization for type II persisting endoleak. The
fourth was the patient with retrograde type A dissection
requiring ascending aorta replacement after 10 days
described above.
Overall, two supra-aortic vessel occlusions (one retro-
pharyngeal and one ante-trachea carotid-carotid bypass),
both asymptomatic, were detected at the 2-month and12-month CTA scan, respectively. Only one was treated
with redo-surgery. No other stent graft proximal migration
or collapse was recorded.
Morphology analysis on surviving patients at follow-up
CTA scan showed that shrinkage $5 mm was detectable in
34 aneurysms with similar rate after total (n ¼ 7) or partial
(n ¼ 27) debranching (46.7% vs 34.2%; P ¼ .26). Four
Table IV. Midterm outcomes at 5 years
Outcome measure No. Description
Late aorta-related mortality 0
Persisting endoleak 6 2 type I
d 1 type Ia @ 24 months
d 1 type Ib @ 41 months
4 type II
Migration 1 associated with type Ib endoleak
Reintervention 5 3 endovascular additional procedures (cuffs/subclavian stump embolization) for endoleak
1 ascending aorta replacement
1 retropharyngeal carotid-carotid-subclavian bypass
Supra-aortic vessel occlusion 2 1 retropharyngeal carotid-carotid-subclavian bypass occlusion @ 10 days
1 ante-trachea carotid-carotid-subclavian bypass occlusion @ 12 months
Stent graft collapse 0
Diameter aneurysm changesa 38 34 diameter shrinkage $5 mm
4 diameter growth $5 mm (3 associated with endoleak)
aNinety-four patients with computed tomography analysis after the perioperative period.
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endoleak and underwent reintervention with subsequent
diameter stabilization or reduction. At 5 years, absence of
growth $5 mm was achieved in 95.7% of aneurysms
undergoing imaging after repair.DISCUSSION
Approach to the aortic arch, regardless of the tech-
nique, cannot be achieved without risks. For open aortic
arch replacement, an operative mortality ranging from
0.9% to 9.3% has been reported in single series from
high-volume centers.15,18-21 However, according to data
from the National Inpatient Sample database22,23 and the
Medicare Provider Analysis and Review,24,25 reﬂecting
the real world experience, operative mortality as high as
15% to 20% has been shown.
After the introduction of endovascular techniques,
a variety of debranching procedures could be applied in
patients with arch diseases with results at least comparable
with those of open surgery at selected centers. The vari-
ability of techniques allows tailoring the procedure to
patient anatomy, comorbidity, and surgical setting.
The data of this study showed that arch endovascular
repair can be applied with 5.8% mortality, 3.8% stroke,
and 2.9% spinal cord ischemia risks. In addition, the efﬁ-
cacy at 5 years was shown in preventing late aorta-related
deaths, and, by the low rates of failures for any type, endo-
leaks and reinterventions.
Nevertheless, proximal extent of arch disease is a major
determinant of outcome. Total arch debranching was
conﬁrmed in our study as an important independent
predictor of 30-day mortality (OR, 9.6; 95% CI,
1.54-59.90; P ¼ .015), even though the wide CIs limited
the predictive value of our results. Similar ﬁndings are
indeed supported by others. Andersen et al found that
native ascending aorta zone 0 stent graft placement was
the only univariate predictor of 30-day mortality (OR,4.63; P ¼ .02) in a series of 87 hybrid arch repairs. Age,
dissection, and nonelective indications were not.9
The recent availability of branched or chimney graft to
allow partial or total supra-aortic vessel revascularization,
limiting the invasiveness of the surgical access, may be
a valid alternative to decrease intraoperative mortality. We
did not record any complications in the six cases per-
formed, but results need to be supported by robust data.
As of today, the reports of late outcomes after arch
endorepair in the long term is not very thorough, with
most series showing results with 15 to 18 months’ mean
follow-up.7,8,12,26 Speciﬁcally, there are few data on endo-
leak rates, with crude rates ranging from 0% to 15%, and
long-term cumulative data virtually absent.1,10,11,26 Czerny
et al recently reported data from a transcontinental registry
including 66 patients with total arch rerouting at a median
follow-up of 25 months, ranging from 8 to 41 months;
only one late type Ib endoleak was found. Five-year aorta
survival was 96%.11 In the series of Vallejo of 38 hybrid
arch repairs, at a mean follow-up of 28.1 months (range,
1-84), there were four type I and two type II endoleaks.8
Andersen, over a mean follow-up of 28 months, found
that 11 of 87 (11%) patients required reintervention for
any type of endoleak.9 A report from Bavaria et al that
focused on arch aneurysms showed only one aortic related
reintervention and no type I and III endoleak at a median
follow-up of 30 months.10
In our study, the cumulative freedom from persisting
endoleak was 88.3% at 5 years and was related to four type
II and two type I endoleaks. Furthermore, only two late
type I endoleaks (at 24 and 41 months) requiring correction
were recorded over the 5-year follow-up. These data support
that, despite the uncommon occurrence of late events, care-
ful imaging surveillance remains an important tool in
ensuring the durability and safety of arch endovascular repair.
Of relevance, all but one of the persisting endoleaks,
including early and late, occurred in patients after zone 1
or 2 repairs. Similar to us, in a review of Kotelis et al of
JOURNAL OF VASCULAR SURGERY
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0 had lower endoleak (3.97% vs 15.48%; P ¼ .005) and
reintervention rates (12% vs 25.8%, P ¼ .032).1 These
data, as well as the low incidence of stent graft migration
(n ¼ 1) recorded in this study, may support the ﬁnding
of other authors in creating a longer and durable proximal
landing zone with aggressive extent to zone 0 for arch
endovascular procedures,13 but still, the improved dura-
bility should be balanced with the higher perioperative risks
of gaining a 2-cm-long implantation site by using zone 0.
There are few data in the literature reporting on late
arch diameter changes after endovascular repair. In this
study, at latest available follow-up, the absence of growth
$5 mm was achieved in 95.7%, indicating successful exclu-
sion of the aneurysm in patients surviving up to 5 years.
Given the sporadic occurrence of periprocedural retro-
grade dissections, no hypotheses on potential causes related
to stent graft design or other factors27,28 can be drawn
from our study. However, although our absolute rate
(3.8%) of retrograde dissections seems low, these results
should be interpreted with caution since only 20% of the
patients in our study were presenting with dissection, the
majority were chronic dissections, and almost half have
had previous ascending aorta replacement. This selection
may have inﬂuenced the rate of retrograde dissection
with respect to rates in arch repairs with native ascending
aorta. In the study of Andersen et al, a similar incidence
of retrograde dissections was reported (3.4%) in a series
of 87 patients with hybrid arch repair. However, authors
pointed out that their true rate would be of 11.1% (3/
27) when including only the patients with native ascending
aorta who were at risk of this complication.9
A major issue in evaluating outcome of arch endovascu-
lar repair relies on patient selection. Most debranching
reports used the updated EUROscore II to stratify high-
risk populations for open surgery in whom endovascular
debranching may be more justiﬁed.9,11,13,29 Nevertheless,
this score, which has been proven to be one of the most reli-
able in predicting mortality after cardiac surgery, was not
always associated with increased mortality risk after arch
debranching procedures.9 Patient selection likely relies not
only on clinical factors but also on surgeons’ boundaries
since safety results with aortic arch treatment can be
achieved in selected centers with large experience in open
surgery or with advanced skills in wiring and catheter manip-
ulation that may allow more extensive endovascular repair.
Limitations. The present report describes more than
100 patients undergoing endovascular arch repair with
different modalities of debranching and represents, to our
knowledge, one of the largest series focused on both clinical
and morphological results after nearly 30 months from
repair. However, we presented a quite heterogeneous group
of patients and procedures, whichmakes comparison among
different treatment options unfeasible. Changes in arch
morphologywere based on crude rates of aneurysmdiameter
measurements and more in-depth analysis at longer follow-
up might be desirable. Finally, the accuracy of our ﬁndings
might be affected by the retrospective analysis of data.CONCLUSIONS
In summary, arch endovascular repair is not equally
safe for all cases and should be carefully applied when
involvement of the ascending aorta requires total arch
rerouting.
However, despite the relevant perioperative mortality
risk, the midterm outcome of endovascular arch repair
with different debranching modalities presents a low
rate of late aorta-related death and reinterventions, and
acceptable 5-year survival. Furthermore, most of the aneu-
rysm diameters (95.7%) shrank or remained stable over
5 years.
Retrograde type A dissection and stroke remain major
concerns in the perioperative period. The 3.8% of retro-
grade type A dissection in this series may be underesti-
mated in patients presenting with dissection and native
ascending aorta.
The implementation of endovascular approaches using
branched stent graft or chimney techniques, associated or
not with partial debranching, might be useful in avoiding
arch manipulations and thereby decreasing the risk of peri-
operative major adverse events, especially in patients
requiring stent graft landing in zone 0. However, this
approach is not yet supported by robust data.
Currently, aortic arch debranching repair relies on
a number of procedural options that need to be tailored
to the individual patient characteristic and center
experience.
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